Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anthony J. Polverino currently holds 150,000 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony J. Polverino has been a net seller of BCLI stock. They have purchased $0 and sold $36.6K worth of shares.
Anthony J. Polverino's most recent insider trade was on Feb 26, 2026, when they sold 150,000 shares at $0.70 per share.
Anthony J. Polverino serves as Executive at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have executed 21 insider transactions totaling $36.6K over their tenure at the company.
Anthony J. Polverino holds the position of Executive at BRAINSTORM CELL THERAPEUTICS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Anthony J. Polverino has shown a selling trading pattern, with $0 in total purchases and $36.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anthony J. Polverino was on Dec 12, 2019, when they sold $412.5K worth of ZYME shares. This transaction involved 27,500 shares at $15.00 per share.
Anthony J. Polverino currently owns 150,000 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anthony J. Polverino's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anthony J. Polverino has 21 Form 4 filings on record as an insider at BRAINSTORM CELL THERAPEUTICS INC..
Set alerts for Anthony J. Polverino and 40,000+ other insiders.